Poseida Therapeutics OverviewPoseida Therapeutics Net Income
Profitability analysis for PSTX.
Quarterly Net Income
$20.23M
↑ 163.68% YoY
As of Sep 2024
Annual Net Income (TTM)
-$59.40M
↑ 55.26% YoY
Trailing 12 months ending Sep 2024
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...